These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33179076)

  • 1. Downregulation of lncRNA ZFAS1 inhibits the hallmarks of thyroid carcinoma via the regulation of miR‑302‑3p on cyclin D1.
    Chen W; Zhai L; Liu H; Li Y; Zhang Q; Xu D; Fan W
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.
    Duan G; Zhang C; Xu C; Xu C; Zhang L; Zhang Y
    Int J Oncol; 2019 Jan; 54(1):17-28. PubMed ID: 30365098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
    Pang R; Yang S
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA ZFAS1 promotes tumorigenesis and metastasis in nasopharyngeal carcinoma by sponging miR-892b to up-regulate LPAR1 expression.
    Peng J; Liu F; Zheng H; Wu Q; Liu S
    J Cell Mol Med; 2020 Jan; 24(2):1437-1450. PubMed ID: 31851778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
    Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
    Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p/RAB9A in melanoma.
    Liang L; Zhang Z; Qin X; Gao Y; Zhao P; Liu J; Zeng W
    Melanoma Res; 2019 Dec; 29(6):569-581. PubMed ID: 30889053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA ZFAS1, as a poor prognostic indicator, promotes cell proliferation and epithelial-mesenchymal transition in endometrial carcinoma.
    Sun Y; Gao X; Li P; Song L; Shi L
    Per Med; 2021 Jan; 18(1):43-53. PubMed ID: 33151128
    [No Abstract]   [Full Text] [Related]  

  • 8. Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis.
    Guo F; Fu Q; Wang Y; Sui G
    J Cell Mol Med; 2019 Sep; 23(9):5907-5919. PubMed ID: 31304680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNA SNHG4 promotes cell proliferation, migration, invasion and the epithelial-mesenchymal transition process via sponging miR-204-5p in gastric cancer.
    Wang S; Zhu W; Qiu J; Chen F
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of long intergenic noncoding RNA LINC00312 inhibits the invasion and migration of thyroid cancer cells by down-regulating microRNA-197-3p.
    Liu K; Huang W; Yan DQ; Luo Q; Min X
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28539331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis.
    Li Z; Qin X; Bian W; Li Y; Shan B; Yao Z; Li S
    J Exp Clin Cancer Res; 2019 Nov; 38(1):477. PubMed ID: 31775815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NORAD regulates epithelial‑mesenchymal transition of non‑small cell lung cancer cells via miR‑422a.
    Chen Z; Che Q; Xie C
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
    Zhou Q; Zhang W; Wang Z; Liu S
    BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
    Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
    Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis.
    Yan F; Ma Y; Liu L; Li L; Deng J; Sun J
    J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma.
    Dasgupta P; Kulkarni P; Majid S; Hashimoto Y; Shiina M; Shahryari V; Bhat NS; Tabatabai L; Yamamura S; Saini S; Tanaka Y; Dahiya R
    Cell Death Dis; 2020 Aug; 11(8):660. PubMed ID: 32814766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA ZFAS1 promotes proliferation and migration and inhibits apoptosis in nasopharyngeal carcinoma via the PI3K/AKT pathway in vitro.
    Wang X; Jin Q; Wang X; Chen W; Cai Z
    Cancer Biomark; 2019; 26(2):171-182. PubMed ID: 31403940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non‑coding RNA TTN‑AS1 regulates the proliferation, invasion and migration of triple‑negative breast cancer by targeting miR‑211‑5p.
    Sun E; Liu X; Lu C; Liu K
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA FEZF1‑AS1 promotes migration, invasion and epithelial‑mesenchymal transition of retinoblastoma cells by targeting miR‑1236‑3p.
    Zhang G; Yang W; Li D; Li X; Huang J; Huang R; Luo J
    Mol Med Rep; 2020 Nov; 22(5):3635-3644. PubMed ID: 32901841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC01816 promotes the migration, invasion and epithelial‑mesenchymal transition of thyroid carcinoma cells by sponging miR‑34c‑5p and regulating CRABP2 expression levels.
    Zhao H; Zhu X; Luo Y; Liu S; Wu W; Zhang L; Zhu J
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.